RIYADH: The Saudi Food and Drug Authority has granted marketing authorization for an artificial intelligence-powered digital medical application capable of measuring heart rate, oxygen saturation, and blood pressure via smartphone cameras.
With this approval, the SFDA becomes the first regulatory authority globally to grant marketing authorization for this application.
The decision came after a comprehensive evaluation that reviewed technical documentation and clinical evidence to verify the application’s safety and performance.
The application employs remote photoplethysmography technology, utilizing advanced algorithms to analyze vital signs from a short facial video.
To ensure accuracy, the application requires an initial blood pressure calibration using a certified medical device.
